PPP2R1B and PPP2R5C

Number of citations of the paper that reports this interaction (PMID 8703017)
87

Data Source:
BioGRID (biochemical, affinity chromatography technology)
HPRD (in vivo)

		PPP2R1B	PPP2R5C
Gene Name		protein phosphatase 2, regulatory subunit A, beta	protein phosphatase 2, regulatory subunit B, gamma
Image		No pdb structure
Gene Ontology Annotations	Cellular Component	Membrane Raft Extracellular Vesicular Exosome	Protein Phosphatase Type 2A Complex Chromosome, Centromeric Region Nucleus
	Molecular Function	Protein Binding	Protein Binding Protein Phosphatase Type 2A Regulator Activity
	Biological Process	Apoptotic Process Involved In Morphogenesis Positive Regulation Of Extrinsic Apoptotic Signaling Pathway In Absence Of Ligand	DNA Damage Response, Signal Transduction By P53 Class Mediator Resulting In Cell Cycle Arrest Signal Transduction Negative Regulation Of Cell Proliferation Intrinsic Apoptotic Signaling Pathway In Response To DNA Damage By P53 Class Mediator Proteasome-mediated Ubiquitin-dependent Protein Catabolic Process Regulation Of Catalytic Activity
Pathways		Signaling by GPCR Integration of energy metabolism Mitotic Prophase misspliced GSK3beta mutants stabilize beta-catenin T41 mutants of beta-catenin aren't phosphorylated ERKs are inactivated truncated APC mutants destabilize the destruction complex TCF7L2 mutants don't bind CTBP Glycolysis Signaling by Wnt Glucose metabolism Toll Like Receptor TLR1:TLR2 Cascade Degradation of beta-catenin by the destruction complex Toll Like Receptor 5 (TLR5) Cascade RNF mutants show enhanced WNT signaling and proliferation Myoclonic epilepsy of Lafora S33 mutants of beta-catenin aren't phosphorylated AXIN mutants destabilize the destruction complex, activating WNT signaling G1/S Transition Glycogen storage diseases MyD88 dependent cascade initiated on endosome Toll Like Receptor 9 (TLR9) Cascade Beta-catenin phosphorylation cascade Mitotic G1-G1/S phases ERK/MAPK targets truncations of AMER1 destabilize the destruction complex misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling TRIF-mediated TLR3/TLR4 signaling Opioid Signalling phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex AXIN missense mutants destabilize the destruction complex S45 mutants of beta-catenin aren't phosphorylated Toll Like Receptor 2 (TLR2) Cascade Platelet homeostasis deletions in the AMER1 gene destabilize the destruction complex Platelet sensitization by LDL AMER1 mutants destabilize the destruction complex Resolution of Sister Chromatid Cohesion Toll Like Receptor 3 (TLR3) Cascade Toll Like Receptor 4 (TLR4) Cascade Metabolism of carbohydrates Mitotic G2-G2/M phases Mitotic Metaphase and Anaphase Adaptive Immune System PP2A-mediated dephosphorylation of key metabolic factors MASTL Facilitates Mitotic Progression Mitotic Prometaphase Costimulation by the CD28 family Separation of Sister Chromatids APC truncation mutants have impaired AXIN binding Toll Like Receptor 7/8 (TLR7/8) Cascade G2/M Transition Mitotic Anaphase Toll Like Receptor TLR6:TLR2 Cascade M Phase APC truncation mutants are not K63 polyubiquitinated disassembly of the destruction complex and recruitment of AXIN to the membrane Activated TLR4 signalling S37 mutants of beta-catenin aren't phosphorylated MyD88 cascade initiated on plasma membrane Cyclin A/B1 associated events during G2/M transition XAV939 inhibits tankyrase, stabilizing AXIN DARPP-32 events MyD88:Mal cascade initiated on plasma membrane TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation Innate Immune System E2F mediated regulation of DNA replication ERKs are inactivated Signalling by NGF MAP kinase activation in TLR cascade CTLA4 inhibitory signaling G1 Phase NGF signalling via TRKA from the plasma membrane MyD88-independent cascade Cell Cycle, Mitotic Toll-Like Receptors Cascades Cyclin D associated events in G1 Toll Like Receptor 10 (TLR10) Cascade TCF dependent signaling in response to WNT ERK/MAPK targets deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling MAPK targets/ Nuclear events mediated by MAP kinases Signaling by WNT in cancer Inhibition of replication initiation of damaged DNA by RB1/E2F1 Nuclear Events (kinase and transcription factor activation)	Mitotic Prometaphase Costimulation by the CD28 family Separation of Sister Chromatids misspliced GSK3beta mutants stabilize beta-catenin APC truncation mutants have impaired AXIN binding T41 mutants of beta-catenin aren't phosphorylated truncated APC mutants destabilize the destruction complex TCF7L2 mutants don't bind CTBP Mitotic Anaphase Signaling by Wnt M Phase APC truncation mutants are not K63 polyubiquitinated disassembly of the destruction complex and recruitment of AXIN to the membrane Degradation of beta-catenin by the destruction complex S37 mutants of beta-catenin aren't phosphorylated RNF mutants show enhanced WNT signaling and proliferation S33 mutants of beta-catenin aren't phosphorylated AXIN mutants destabilize the destruction complex, activating WNT signaling XAV939 inhibits tankyrase, stabilizing AXIN Beta-catenin phosphorylation cascade truncations of AMER1 destabilize the destruction complex misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling CTLA4 inhibitory signaling phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex AXIN missense mutants destabilize the destruction complex S45 mutants of beta-catenin aren't phosphorylated Cell Cycle, Mitotic Platelet homeostasis deletions in the AMER1 gene destabilize the destruction complex TCF dependent signaling in response to WNT Platelet sensitization by LDL AMER1 mutants destabilize the destruction complex Resolution of Sister Chromatid Cohesion deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling Signaling by WNT in cancer Mitotic Metaphase and Anaphase Adaptive Immune System
Drugs
Diseases
GWAS			Autism ( 20663923)
Protein-Protein Interactions		31 interactors: AKAP9 ANXA5 BSG CDK1 CDK4 CFTR EEF2 FGFR1OP HDAC1 HSPD1 JAK2 MCM3 PARK7 PPP2CA PPP2R2A PPP2R3B PPP2R5C PPP2R5D PPP2R5E PRDX1 PRDX2 RAB11A RAB18 RAB7A RALA RELA SET SGOL1 SGOL2 STRN STRN3	14 interactors: APP AXIN1 BRCA1 CHEK2 EP300 IER3 MAPK1 MBP PAXIP1 PPP2CA PPP2R1B PRKCD PXN SGOL1
Entrez ID		5519	5527
HPRD ID		04384	03385
Ensembl ID		ENSG00000137713	ENSG00000078304
Uniprot IDs		P30154	Q13362
PDB IDs			2IAE 2JAK 2NPP 2NYL 2NYM 3FGA
Enriched GO Terms of Interacting Partners?		Mitotic Cell Cycle Cell Cycle Cell Cycle Process Mitotic Cell Cycle Process Response To Organic Substance Mitotic Cell Cycle Phase Transition Cell Cycle Phase Transition Organelle Organization Cellular Response To Stimulus Cellular Response To Oxidative Stress Cellular Response To Reactive Oxygen Species Ras Protein Signal Transduction Signal Transduction Regulation Of Catalytic Activity Response To Stimulus Signaling Negative Regulation Of Apoptotic Process Negative Regulation Of Programmed Cell Death Response To Inorganic Substance Cell Communication Regulation Of Cellular Process MyD88-dependent Toll-like Receptor Signaling Pathway Negative Regulation Of Cell Death Response To Reactive Oxygen Species Regulation Of Schwann Cell Differentiation Neurotrophin TRK Receptor Signaling Pathway Regulation Of Apoptotic Process Neurotrophin Signaling Pathway Regulation Of Cellular Amino Acid Metabolic Process Response To Organic Cyclic Compound Intracellular Signal Transduction Hydrogen Peroxide Metabolic Process Toll-like Receptor Signaling Pathway Response To Oxidative Stress Regulation Of Cell Death Cell Division Regulation Of Innate Immune Response Positive Regulation Of Protein Metabolic Process Endomembrane System Organization G2/M Transition Of Mitotic Cell Cycle Response To CAMP Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway Pattern Recognition Receptor Signaling Pathway Innate Immune Response-activating Signal Transduction Regulation Of Metabolic Process Chromosome Organization Activation Of Innate Immune Response Regulation Of Cellular Ketone Metabolic Process Reproduction Response To Organophosphorus	Apoptotic Process Programmed Cell Death Cell Death Death Regulation Of Cellular Amino Acid Metabolic Process Regulation Of Protein Metabolic Process Positive Regulation Of Protein Metabolic Process Regulation Of Cellular Ketone Metabolic Process Cellular Response To Stress Positive Regulation Of Cellular Protein Metabolic Process Intrinsic Apoptotic Signaling Pathway Developmental Process Positive Regulation Of Metabolic Process Response To Stress Positive Regulation Of Cellular Metabolic Process Intracellular Signal Transduction Cell Cycle Regulation Of Cellular Protein Metabolic Process Intrinsic Apoptotic Signaling Pathway In Response To DNA Damage Positive Regulation Of Protein Modification Process Regulation Of Signal Transduction Regulation Of MAP Kinase Activity Regulation Of Signaling Positive Regulation Of Cellular Biosynthetic Process Regulation Of Protein Stability Apoptotic Signaling Pathway Cellular Protein Modification Process Signaling Regulation Of Protein Kinase Activity Cell Communication Regulation Of Kinase Activity Regulation Of Cellular Component Organization Positive Regulation Of Transcription, DNA-templated Cellular Response To DNA Damage Stimulus Posttranscriptional Regulation Of Gene Expression Anatomical Structure Development Negative Regulation Of Cellular Metabolic Process Positive Regulation Of Macromolecule Biosynthetic Process Positive Regulation Of Gene Expression Signal Transduction Cell Cycle Process Positive Regulation Of Protein Serine/threonine Kinase Activity Regulation Of Protein Phosphorylation Regulation Of MAPK Cascade Anatomical Structure Morphogenesis Response To Abiotic Stimulus Cellular Protein Metabolic Process Protein Stabilization Signal Transduction In Response To DNA Damage Positive Regulation Of Histone H3-K4 Methylation
Tagcloud ?			3beta annexin ataxia atm cck downregulated efficient glycogen gsk homolog interference jurkat leukemias leukemic mdm2 molt nonsilencing nucleofection pi qrt scrambled sirna sirna2 sirnas tcr telangiectasia transfected treat twofold
Tagcloud (Difference) ?			3beta annexin ataxia atm cck downregulated efficient glycogen gsk homolog interference jurkat leukemias leukemic mdm2 molt nonsilencing nucleofection pi qrt scrambled sirna sirna2 sirnas tcr telangiectasia transfected treat twofold
Tagcloud (Intersection) ?